---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-034724"
form_type: "8-K"
ticker: "JUNS"
cik: "0001679628"
company_name: "JUPITER NEUROSCIENCES, INC."
filed_at: "2026-07-27T13:00:41+00:00"
generated_at: "2026-07-27T13:02:15.477849+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Jupiter Neurosciences shareholders approve reverse stock split (1:10-1:100) and 5.25M share equity plan increase

## Summary
- Shareholders approved reverse stock split at ratio between 1:10 and 1:100, with board discretion on timing and ratio.
- Equity incentive plan amended to increase authorized shares by 5,250,000 shares.
- All seven director nominees elected; Cherry Bekaert ratified as auditor for FY2026.
- Under SEPA with Yorkville, ~$1.5M convertible notes outstanding; ~12.5M shares issued for ~$4.1M net proceeds.

## SEC filing metadata
- accession: 0001493152-26-034724
- form_type: 8-K
- ticker: JUNS
- cik: 0001679628
- company_name: JUPITER NEUROSCIENCES, INC.
- filed_at: 2026-07-27T13:00:41+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/0001493152-26-034724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-034724
- JSON: https://secwatch.observer/filing/0001493152-26-034724.json
- Plain text: https://secwatch.observer/filing/0001493152-26-034724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.